GlassScriptPhysician profile
Ausim Chaghtai
NPI 1164817516
$9,444.52
in general payments reported to CMS, 2019-2025
27 companies · $7,102 in 2025
The $7,102 reported for 2025 was more than what 87% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $187 · 2021: $223 · 2022: $109 · 2023: $730 · 2024: $1,093 · 2025: $7,102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,126 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Consulting Fee: $1,800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,126.16 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Consulting Fee | $1,800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $5,144.76 | 2023-2025 | |
| Abbvie INC. | $1,495.48 | 2023-2025 | Ubrelvy, Qulipta, Botox |
| Lundbeck LLC | $530.57 | 2023-2025 | Vyepti |
| Lilly USA, LLC | $393.33 | 2024-2025 | Kisunla, Emgality, Amyvid |
| Eisai INC. | $275.24 | 2024-2025 | |
| Insightec,INC | $258.84 | 2023-2025 | Exablate |
| Biodelivery Sciences International, INC. | $185.81 | 2020-2021 | |
| Axsome Therapeutics, INC. | $176.39 | 2025 | Symbravo |
| Genentech USA, INC. | $153.36 | 2024-2025 | Ocrevus, Ocrevus Zunovo |
| Boston Scientific Corporation | $149.81 | 2020-2025 | Wavewriter Alpha Prime 16 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $104.78 | 2021-2022 | |
| Medtronic USA, INC. | $76.52 | 2020 | |
| Medtronic, INC. | $68.82 | 2024 | Intellis Adaptivestim |
| Stryker Corporation | $68.34 | 2024 | Spinejack, Optablate |
| Ge Healthcare | $61.13 | 2024-2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $45.00 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $42.09 | 2025 | Ponvory |
| Allergan, INC. | $32.46 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.87 | 2025 | Hyqvia |
| Abbott Laboratories | $22.68 | 2023 | Infinity |
| Impel Pharmaceuticals INC. | $22.04 | 2023 | Trudhesa |
| Redhill Biopharma INC. | $22.01 | 2021 | |
| Amneal Pharmaceuticals LLC | $21.93 | 2023 | Rytary |
| Harmony Biosciences LLC | $20.78 | 2025 | |
| Merz Pharmaceuticals, LLC | $20.53 | 2025 | Xeomin |
| Novo Nordisk INC | $14.30 | 2024 | Saxenda, Wegovy |
| Biohaven Pharmaceuticals, INC. | $12.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ausim Chaghtai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.